- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T […]
The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”
The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).
The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk
Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.
From undergraduate students to post-doctoral fellows – every set of hands is important.